TALIS BIOMEDICAL CORP (TLIS) Stock Price & Overview
NASDAQ:TLIS • US87424L2079
Current stock price
The current stock price of TLIS is 4.38 USD. Today TLIS is up by 5.29%. In the past month the price decreased by -50.79%. In the past year, price decreased by -27.24%.
TLIS Key Statistics
- Market Cap
- 7.972M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -31.43
- Dividend Yield
- N/A
TLIS Stock Performance
TLIS Stock Chart
TLIS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to TLIS. When comparing the yearly performance of all stocks, TLIS is a bad performer in the overall market: 91.67% of all stocks are doing better.
TLIS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TLIS. While TLIS has a great health rating, there are worries on its profitability.
TLIS Earnings
TLIS Forecast & Estimates
6 analysts have analysed TLIS and the average price target is 5.1 USD. This implies a price increase of 16.44% is expected in the next year compared to the current price of 4.38.
For the next year, analysts expect an EPS growth of 27.62% and a revenue growth -100% for TLIS
TLIS Groups
Sector & Classification
TLIS Financial Highlights
Over the last trailing twelve months TLIS reported a non-GAAP Earnings per Share(EPS) of -31.43. The EPS increased by 42.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.35% | ||
| ROE | -100.93% | ||
| Debt/Equity | 0 |
TLIS Ownership
TLIS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.1 | 180.7B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.29 | 160.771B | ||
| SYK | STRYKER CORP | 21.65 | 125.308B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.78 | 102.641B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.33 | 46.081B | ||
| IDXX | IDEXX LABORATORIES INC | 37.66 | 44.453B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 43.995B | ||
| RMD | RESMED INC | 17.95 | 32.118B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.39 | 31.552B | ||
| DXCM | DEXCOM INC | 24.49 | 23.958B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.45 | 17.329B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.893B | ||
| PODD | INSULET CORP | 32.21 | 14.659B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TLIS
Company Profile
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
Company Info
IPO: 2021-02-12
TALIS BIOMEDICAL CORP
1375 West Fulton Market, Suite 700
Chicago ILLINOIS 94025 US
CEO: Brian Coe
Employees: 99
Phone: 16504333000
TALIS BIOMEDICAL CORP / TLIS FAQ
Can you describe the business of TALIS BIOMEDICAL CORP?
Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.
Can you provide the latest stock price for TALIS BIOMEDICAL CORP?
The current stock price of TLIS is 4.38 USD. The price increased by 5.29% in the last trading session.
Does TLIS stock pay dividends?
TLIS does not pay a dividend.
How is the ChartMill rating for TALIS BIOMEDICAL CORP?
TLIS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is TLIS stock listed?
TLIS stock is listed on the Nasdaq exchange.
What is the market capitalization of TLIS stock?
TALIS BIOMEDICAL CORP (TLIS) has a market capitalization of 7.97M USD. This makes TLIS a Nano Cap stock.